Modern Diagnostic & Research Centre IPO Subscription Status

BSE SME
Minimum investment
₹ 2,88,000 3200 shares
View IPO details

Data sourced from BSE · Compiled by IPO Ji · IPO subscription data last updated

Total 376.97x·QIB 193.51x·NII 702.43x·Individual 342.46x

≈ 1 in 342 individual allotmentslim allotment chance

Based on individual subscription by applications (342.46×), approximately 1 in 342 individual applications may receive an allotment. Final allotment is decided by the registrar’s computerised lottery.

Modern Diagnostic & Research Centre Limited SME IPO was subscribed 376.97x in total when bidding closed on Jan 2, 2026, with 193.51x in the QIB category, 702.43x in NII, 342.46x in individual across BSE. This represents a strong oversubscription, reflecting heavy investor demand; a high subscription figure does not guarantee listing gains, and allotment follows the applicable category and exchange rules. The issue ran from Dec 31, 2025 to Jan 2, 2026 at a price band of ₹85–₹90 per share. Allotment was finalised on Jan 5, 2026.

QIB193.51xNII702.43xIndividual342.46xTotal376.97x1x
Times subscribed by category against the 1× fully-subscribed line (bars capped at 10×).
Advertisement
Advertisement

Subscription Details (No. of Shares)

Category Offer Applied Times
QIBs 782400 151400000 193.51
NIIs 585600 411345600 702.43
BNIIs (>10L) 390400 337059200 863.37
SNIIs (<10L) 195200 74286400 380.57
Individual 1363200 466844800 342.46
Total 2731200 1029590400 376.97
Total Applications1,89,518 approx.

Application Wise Breakup (Approx.)

Category Reserve Applied Times
BNIIs (>10L) 81 28,729 354.68
SNIIs (<10L) 41 14,791 360.76
Individual 426 1,45,889 342.46
Total Applications1,89,518 approx.

Subscription Details (In Crores)

Category Offered Demand Times
QIBs 7.04 1362.6 193.51
FIIs - 277.65 -
DIIs - 37.60 -
Mutual Funds - 0.00 -
Others - 1047.36 -
NIIs 5.27 3702.11 702.43
BNIIs (>10L) 3.51 3033.53 863.37
SNIIs (<10L) 1.76 668.58 380.57
Individual 12.27 4201.6 342.46
TOTAL 24.58 9266.31 376.97

Day-wise subscription

Total subscription trend5.92x to 376.97x+371.05x
0.00x376.97x1x5.92xDay 130.94xDay 2376.97xDay 3
As on QIB
NII
bHNI
sHNI
Individual Total
Day 1
31 Dec 2025
5:00 PM
4.01x
9.42x
11.86x
4.56x
5.51x 5.92x
Day 2
1 Jan 2026
5:00 PM
8.94x
53.57x
64.47x
31.77x
33.85x 30.94x
Day 3
2 Jan 2026
5:00 PM
193.51x
702.43x
863.37x
380.57x
342.46x 376.97x

Subscription by number of applications

Anticipated subscription based on the number of applications received (an alternative to the shares-based figures above), sourced from BSE.

CategoryTimes (by applications)
bHNI354.68x
sHNI360.76x
Individual342.46x

What this means for allotment & listing

Because Modern Diagnostic & Research Centre closed oversubscribed, applicants were not guaranteed full allotment. In oversubscribed issues, shares are allotted according to the applicable category and exchange rules, so applicants are not guaranteed full allotment once an issue is oversubscribed. The number of times each category is subscribed is one indicator of demand, alongside the company's fundamentals and the broader market.

A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice. Investors should read the company's prospectus and consult a SEBI-registered adviser before making any decision.

Listed at BSE SME · Registrar: MUFG Intime India Pvt.Ltd. · Bidding data sourced from the BSE public-issue platform under SEBI ICDR regulations.

IPO subscription status shows how many times an issue has been applied for, compared with the shares on offer, broken down by Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII), and the Retail or SME Individual Investor category. A figure of "2x" means investors applied for twice the shares available. See how IPO subscription works and track all live IPOs →

Modern Diagnostic & Research Centre IPO subscription FAQs

Modern Diagnostic & Research Centre Limited IPO was subscribed 376.97x at close on Jan 2, 2026, with 193.51x in QIB, 702.43x in NII, 342.46x in individual.

Yes. Modern Diagnostic & Research Centre IPO was subscribed 376.97x, meaning investors applied for 376.97x the number of shares on offer.

Based on individual subscription by applications (about 342.46x), approximately 1 in 342 individual applications may receive an allotment. This is an estimate — the final allotment is decided by the registrar's computerised lottery, and the odds can change while bidding is open.

The Modern Diagnostic & Research Centre IPO allotment was finalised on Jan 5, 2026. You can check your allotment status by PAN or application number on the registrar's website or on IPO Ji.

Modern Diagnostic & Research Centre IPO has a price band of ₹85–₹90 per share, with a minimum individual investor application of ₹2,88,000 for 3200 shares.

It means investors have applied for X times the number of shares the company is offering. For example, 5x means demand was five times the shares available. A figure above 1x is called oversubscription; below 1x is undersubscription.

No. The higher an issue is oversubscribed, the lower each applicant’s chance of allotment. SME shares are allotted according to the applicable Individual Investor, NII and exchange rules, so oversubscription does not guarantee full allotment.

QIB covers qualified institutions. Under the current SME IPO framework, an Individual Investor applies for the minimum application size of two lots above ₹2 lakh, while applicants bidding for more than two lots are classified in the NII category. Each category has its own reserved portion and allotment rules.

IPO Ji updates subscription figures through the bidding day using data sourced from BSE. The "Last updated" time shown on the page reflects the most recent refresh.

Other live IPO subscriptions

Advertisement
Important Disclaimer

Data Source: The above information / data is sourced from National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to change in real time. For latest information / data, please refer to the respective websites.

Purpose: The information / data provided herein is for informational purposes only and is provided by ipoji.com on "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied.

Accuracy: ipoji.com does not warrant the accuracy, adequacy or completeness of the information you obtain through the above websites.

Liability: ipoji.com shall not be liable in any way for any discrepancies, errors, omissions, losses or damage. ipoji.com, including its affiliates and its directors, staff and employees, shall not be liable for any loss, damage of any kind, including but not limited to direct, indirect, punitive, exemplary, consequential damages and lost profits arising in any way out of the use of information / data obtained through the said websites.

User Responsibility: The recipient alone is fully responsible / liable for any decision made based on this information / data. All recipients, before relying on the said information, should do their own research and seek appropriate professional advice.